A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00002195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Trial to Evaluate the Safety and Antiviral Efficacy of 141W94 in Combination With Retrovir and Epivir Compared to Retrovir and Epivir Alone in Patients With HIV Infection.
Study identification
- NCT ID
- NCT00002195
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- 290 participants
Conditions and interventions
Conditions
Interventions
- Amprenavir Drug
- Lamivudine Drug
- Zidovudine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| Dr Bruce Rashbaum | Washington D.C. | District of Columbia | 20037 | — |
| Community Research Initiative of South Florida | Coral Gables | Florida | 33146 | — |
| Community Research Initiative of Central Florida | Maitland | Florida | 32751 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| Chicago Ctr for Clinical Research | Chicago | Illinois | 60610 | — |
| Community Research Initiative of New England | Brookline | Massachusetts | 02445 | — |
| Saint Vincent's AIDS Ctr | New York | New York | 10011 | — |
| Methodist Hosp | Memphis | Tennessee | 38104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002195 live on ClinicalTrials.gov.